Since the rediscovery of Helicobacter pylori (H. pylori) in the early 1980's, studies have now demonstrated that H. pylori plays an etiologic role in the development of gastritis, peptic ulcer disease, and gastric cancer. The investigators have previously demonstrated the importance of the host as a factor in disease outcome following gastric Helicobacter infection. A related issue, is whether the host immune response contributes to the pathogenesis or acts to protect the host from infection. Using the H.felis/mouse model, the investigators have demonstrated that the T-cell mediated immune response to Helicobacter infection can contribute either to the pathogenesis or act in concert with the humoral immune response to clear this infection. Specifically, the results of studies funded during the previous granting period indicate the Helicobacter infection activates antigen specific cell-mediated immune responses in immunized or infected hosts. These responses have a phenotype which is either pro-inflammatory in nature (TH1) or protective in nature (TH2). Adoptive transfer of Helicobacter-specific TH1 lymphocytes exacerbates gastric inflammation in recipients. However, transfer of a TH2 cell line from immunized/protected mice decreases the magnitude of infection in the recipients. There continues to be a number of unanswered questions, however, which are the focus of this proposal. Using the recently developed H. pylori/mouse model, a number of contemporary techniques, such as the use of knock-out or transgenic mice, recombinant cytokine therapy, and adoptive transfer studies, will be used to further investigate the role of the host immune response in preventing or promoting chronic H. pylori gastroduodenal disease. the investigators will specifically assess the contribution of the humoral immune system in preventing H. pylori gastroduodenal disease following immunization as well as assess the contribution of the host cellular immune response in preventing or promoting H. pylori gastroduodenal disease. An in-depth understanding of the pro-inflammatory mechanisms employed by the host in this model will contribute to our general understanding of immune regulation and the pathogenesis of infectious disease. Finally, these aims are a logical extension of the work previously performed in their laboratory and may ultimately allow them to develop a safe and efficacious sub-unit vaccine to prevent morbidity and potential long-term consequences of Helicobacter infection.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Banerjee, Aditi; Basu, Malini; Blanchard, Thomas G et al. (2016) Early Molecular Events in Murine Gastric Epithelial Cells Mediated by Helicobacter pylori CagA. Helicobacter 21:395-404
Zawahir, Sharmila; Li, Guanghui; Banerjee, Aditi et al. (2015) Inflammatory and Immune Activation in Intestinal Myofibroblasts Is Developmentally Regulated. J Interferon Cytokine Res 35:634-40
Shiu, J; Piazuelo, M B; Ding, H et al. (2015) Gastric LTi cells promote lymphoid follicle formation but are limited by IRAK-M and do not alter microbial growth. Mucosal Immunol 8:1047-59
Zawahir, Shamila; Czinn, Steven J; Nedrud, John G et al. (2013) Vaccinating against Helicobacter pylori in the developing world. Gut Microbes 4:568-76
Shiu, Jessica; Czinn, Steven J; Kobayashi, Koichi S et al. (2013) IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori. PLoS One 8:e66914
Blanchard, Thomas G; Czinn, Steven J; Correa, Pelayo et al. (2013) Genome sequences of 65 Helicobacter pylori strains isolated from asymptomatic individuals and patients with gastric cancer, peptic ulcer disease, or gastritis. Pathog Dis 68:39-43
Ding, Hua; Nedrud, John G; Blanchard, Thomas G et al. (2013) Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS One 8:e69384
von Rosenvinge, Erik C; Song, Yang; White, James R et al. (2013) Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 7:1354-66
Blanchard, Thomas G; Nedrud, John G (2012) Laboratory maintenance of Helicobacter species. Curr Protoc Microbiol Chapter 8:Unit8B.1
DeLyria, Elizabeth S; Nedrud, John G; Ernst, Peter B et al. (2011) Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter 16:169-78

Showing the most recent 10 out of 48 publications